These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3443392)

  • 21. Amplified expression of murine leukemia virus (MuLV)-coded antigens on thymocytes and leukemia cells of AKR mice after infection by dualtropic (MCF) MuLV.
    O'Donnell PV; Nowinski RC; Stockert E
    Virology; 1982 Jun; 119(2):450-64. PubMed ID: 6177096
    [No Abstract]   [Full Text] [Related]  

  • 22. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen.
    Green WR
    J Immunol; 1980 Dec; 125(6):2584-90. PubMed ID: 6159413
    [No Abstract]   [Full Text] [Related]  

  • 23. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

  • 24. Retrovirus antigens recognized by cytolytic T lymphocytes activate tumor rejection in vivo.
    Plata F; Langlade-Demoyen P; Abastado JP; Berbar T; Kourilsky P
    Cell; 1987 Jan; 48(2):231-40. PubMed ID: 3026637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential induction of H-2K versus H-2D class I major histocompatibility antigens by recombinant gamma interferon. Lack of Kk augmentation in a leukemia virus-induced tumor is due to a cis-dominant effect.
    Green WR; Rich RF; Beadling C
    J Exp Med; 1988 May; 167(5):1616-24. PubMed ID: 3130455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic control of CTL responses to AKR/Gross virus: effect of inheritance of Akv proviruses.
    Green WR; Rich RF
    Immunogenetics; 1988; 27(5):304-12. PubMed ID: 2833435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in H-2 antigen expression on a murine spontaneous leukaemia (K36) detected by cell-mediated cytotoxicity assay.
    Testorelli C; Marelli O; Schmidt W; Festenstein H
    J Immunogenet; 1980 Feb; 7(1):19-29. PubMed ID: 6154749
    [No Abstract]   [Full Text] [Related]  

  • 29. Induction of tumour-specific immunity by manipulating the expression of major histocompatibility complex molecules on tumour cells.
    Hui KM
    FEMS Microbiol Immunol; 1990 Nov; 2(4):215-21. PubMed ID: 2285518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine leukaemia virus group-specific antigen in tumor-resistant tetraparental AKR reversible CBA/H-T6 chimaeras.
    Barnes RD; Tuffrey M; Holliday J; Hilgers JH; Souissi T
    Br J Cancer; 1976 Jul; 34(1):28-38. PubMed ID: 182191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and viral factors influencing the development of spontaneous leukemia in AKR mice.
    Nowinski RC; Brown M; Doyle T; Prentice RL
    Virology; 1979 Jul; 96(1):186-204. PubMed ID: 223299
    [No Abstract]   [Full Text] [Related]  

  • 32. Expression of CTL-defined, AKR/Gross retrovirus-associated tumor antigens by normal spleen cells: control by Fv-1, H-2, and proviral genes and effect on antiviral CTL generation.
    Green WR
    J Immunol; 1986 Jan; 136(1):308-12. PubMed ID: 2999246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
    Wustrow TP; Good RA
    Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo.
    Green WR
    J Immunol; 1982 Mar; 128(3):1043-9. PubMed ID: 6976986
    [No Abstract]   [Full Text] [Related]  

  • 35. COMPARISON OF TUMOUR ANTIGENS IN AKR AND GROSS VIRUS (PASSAGE A)-INDUCED LEUKAEMIAS.
    WAHREN B
    Nature; 1965 Jan; 205():409-10. PubMed ID: 14243441
    [No Abstract]   [Full Text] [Related]  

  • 36. A discrepancy in XC and oncogenicity assays for murine leukemia virus in AKR mice.
    Hays EF; Vredevoe DL
    Cancer Res; 1977 Mar; 37(3):726-30. PubMed ID: 189912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in RNA tumor virus expression in H-2 congenic leukemia cell lines.
    Wolfe JH; Blank KJ; Pincus T
    Immunogenetics; 1981; 12(1-2):187-90. PubMed ID: 7203555
    [No Abstract]   [Full Text] [Related]  

  • 38. AKR mouse leukemic cells in tissue culture. II. Immunologic studies on the AKR 87 cell line.
    Duś D; Harlozińska A; Skriabin A; Richter R
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):727-40. PubMed ID: 187141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-dependent leukemia produced in thymectomized AKR mice by antiserum to leukemic cells.
    Kohn RR; Sciotto CG; Hensse S
    Exp Gerontol; 1978; 13(3-4):181-7. PubMed ID: 689114
    [No Abstract]   [Full Text] [Related]  

  • 40. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R; Graziano RF; Green WR
    J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.